| QNRX |
Quoin Pharmaceuticals Ltd. |
Ordinary Shares, no par value per share |
9% |
$13.7M |
|
1.9M |
|
Integrated Core Strategies (US) LLC |
Oct 20, 2025 |
| TENX |
Tenax Therapeutics, Inc. |
Common Stock, par value $0.0001 per share |
6.9% |
$1.88M |
$481K |
314K |
+34.3% |
Integrated Core Strategies (US) LLC |
Sep 30, 2025 |
| SRZN |
Surrozen, Inc. |
Common Stock, par value $0.0001 per share |
6.6% |
$7.69M |
|
565K |
|
Millennium Management LLC |
Nov 13, 2025 |
| AMN |
AMN Healthcare Services, Inc. |
Common Stock, par value $0.01 per share |
6.4% |
$47.4M |
|
2.45M |
|
Millennium Management LLC |
Nov 4, 2025 |
|
Harvard Ave Acquisition Corporation |
Class A Ordinary Shares, par value $0.0001 per share |
6.4% |
|
|
950K |
|
Millennium Management LLC |
Oct 23, 2025 |
| ZEPP |
Zepp Health Corporation |
Class A Ordinary Shares, par value $0.0001 per share |
5.8% |
$304M |
|
6.63M |
|
Millennium Management LLC |
Nov 5, 2025 |
| KIDS |
OrthoPediatrics Corp. |
Common Stock, par value $0.00025 per share |
5.5% |
$25.8M |
|
1.39M |
|
Millennium Management LLC |
Oct 29, 2025 |
| LIVN |
LivaNova PLC |
Ordinary Shares, par value GBP 1.00 per share |
5.4% |
$156M |
$47.4M |
2.97M |
+43.8% |
Millennium Management LLC |
Sep 30, 2025 |
| UTZ |
Utz Brands, Inc. |
Class A Common Stock, par value $0.0001 per share |
5.3% |
$60.5M |
|
4.52M |
|
Millennium Management LLC |
May 23, 2025 |
| ANGO |
AngioDynamics, Inc. |
Common Stock, par value $0.01 per share |
5.3% |
$20.7M |
|
2.15M |
|
Millennium Management LLC |
Jul 16, 2025 |
| BTAI |
BioXcel Therapeutics, Inc. |
Common Stock, par value $0.001 per share |
5.2% |
$3.49M |
|
1.03M |
|
Millennium Management LLC |
Sep 29, 2025 |
| MYGN |
Myriad Genetics, Inc. |
Common Stock, par value $0.01 per share |
5.1% |
$34.3M |
-$1.28M |
4.75M |
-3.58% |
Millennium Management LLC |
Sep 30, 2025 |
| CYRX |
Cryoport, Inc. |
Common Stock, par value $0.001 per share |
5.1% |
$23M |
$3.14M |
2.56M |
+15.8% |
Millennium Management LLC |
Sep 24, 2025 |
| FHN |
First Horizon Corporation |
Common Stock, par value $0.625 per share |
5% |
$574M |
|
25.4M |
|
Millennium Management LLC |
Oct 16, 2025 |
| SLRN |
ACELYRIN, INC. |
Common Stock, par value $0.00001 per share |
4.7% |
$10.5M |
|
4.71M |
|
Integrated Core Strategies (US) LLC |
Dec 31, 2024 |
| HLXB |
Helix Acquisition Corp. II |
Class A Ordinary Shares, par value $0.0001 per share |
4.7% |
$9.88M |
|
897K |
|
Millennium Management LLC |
Jun 30, 2025 |
| ADPT |
Adaptive Biotechnologies Corporation |
Common Stock, par value $0.0001 per share |
4.3% |
$52.7M |
|
6.29M |
|
Millennium Management LLC |
Dec 31, 2024 |
| ENTA |
Enanta Pharmaceuticals, Inc. |
Common Stock, par value $0.01 per share |
4.1% |
$13.6M |
-$2.92M |
1.14M |
-17.6% |
Millennium Management LLC |
Sep 30, 2025 |
| PYXS |
Pyxis Oncology, Inc. |
Common Stock, par value $0.001 per share |
4% |
$2.39M |
-$645K |
2.49M |
-21.3% |
Millennium Management LLC |
Mar 31, 2025 |
| CPIX |
Cumberland Pharmaceuticals Inc. |
Common Stock, no par value |
4% |
$1.62M |
-$571K |
599K |
-26.1% |
Integrated Core Strategies (US) LLC |
Sep 30, 2025 |
| ACCD |
Accolade, Inc. |
Common Stock, par value $0.0001 per share |
3.8% |
$21.7M |
|
3.09M |
|
Millennium Management LLC |
Dec 31, 2024 |
| SEE |
Sealed Air Corporation |
Common Stock, par value $0.10 per share |
3.7% |
$181M |
-$72.1M |
5.4M |
-28.5% |
Millennium Management LLC |
Nov 11, 2025 |
| CMA |
Comerica Incorporated |
Common Stock, par value $5 per share |
3.6% |
$316M |
-$279M |
4.61M |
-46.9% |
Millennium Management LLC |
Oct 7, 2025 |
| AMG |
Affiliated Managers Group, Inc. |
Common Stock, par value $0.01 per share |
3.6% |
$243M |
-$117M |
1.02M |
-32.5% |
Millennium Management LLC |
Sep 30, 2025 |
| LXEO |
Lexeo Therapeutics, Inc. |
Common Stock, par value $0.0001 per share |
3.2% |
$15.4M |
-$3.47M |
2.31M |
-18.4% |
Millennium Management LLC |
Sep 30, 2025 |
| GVA |
Granite Construction Incorporated |
Common Stock, par value $0.01 per share |
3% |
$99.6M |
|
1.28M |
|
Millennium Management LLC |
Mar 31, 2025 |
| NKTR |
Nektar Therapeutics |
Common Stock, par value $0.0001 per share |
3% |
$32.5M |
-$20.6M |
571K |
-38.8% |
Millennium Management LLC |
Sep 30, 2025 |
| CMPS |
COMPASS Pathways plc |
American Depositary Shares, each representing one ordinary share, par value of GBP 0.008 per share |
3% |
$7.9M |
-$1.82M |
2.77M |
-18.7% |
Millennium Management LLC |
Mar 31, 2025 |
| NEO |
NeoGenomics, Inc. |
Common Stock, par value $0.001 per share |
2.8% |
$27.5M |
-$26.1M |
3.57M |
-48.7% |
Millennium Management LLC |
Jun 30, 2025 |
| UWMC |
UWM Holdings Corporation |
Class A Common Stock, par value $0.0001 per share |
2.5% |
$20.9M |
-$32.3M |
4.97M |
-60.7% |
Millennium Management LLC |
Jun 30, 2025 |
| ABEO |
Abeona Therapeutics Inc. |
Common Stock, par value $0.01 per share |
1.7% |
$3.54M |
|
810K |
|
Millennium Management LLC |
Mar 31, 2025 |
| MIST |
Milestone Pharmaceuticals Inc. |
Common Shares, no par value |
0.6% |
$248K |
|
322K |
|
Integrated Core Strategies (US) LLC |
Mar 31, 2025 |
| ATXS |
Astria Therapeutics, Inc. |
Common Stock, par value $0.001 per share |
0.4% |
$1.62M |
-$19.8M |
222K |
-92.4% |
Millennium Management LLC |
Oct 14, 2025 |
| ANIP |
ANI Pharmaceuticals, Inc. |
Common Stock, par value $0.0001 per share |
0.3% |
$5.98M |
-$96.3M |
65.2K |
-94.2% |
Millennium Management LLC |
Sep 30, 2025 |
| PHIN |
PHINIA Inc. |
Common Stock, par value $0.01 per share |
0% |
$0 |
|
0 |
|
Integrated Core Strategies (US) LLC |
Mar 31, 2025 |
| GLNG |
Golar LNG Limited |
Common Shares, par value $1.00 per share |
0% |
$0 |
-$193M |
0 |
-100% |
Integrated Core Strategies (US) LLC |
Mar 31, 2025 |